Toronto Dominion Bank
STOK icon

Toronto Dominion Bank’s Stoke Therapeutics STOK Stock Holding History

Toronto Dominion Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103M Hold
3,173,258
– – 0.15% 126
2025
Q4 		$101M Hold
3,173,258
– – 0.15% 137
2025
Q3 		$74.6M Hold
3,173,258
– – 0.12% 164
2025
Q2 		$36M Hold
3,173,258
– – 0.06% 260
2025
Q1 		$21.1M Hold
3,173,258
– – 0.04% 317
2024
Q4 		$35M Buy
+3,173,258
New +$39M 0.06% 237

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Toronto Dominion Bank's STOK Position: Q1 2026 in Review

Toronto Dominion Bank held its Stoke Therapeutics (STOK) position steady in Q1 2026 at 3,173,258 shares worth $103M. The position accounts for 0.15% of the portfolio, ranked #126.

Toronto Dominion Bank first reported a position in STOK in Q4 2024 and has held it in 6 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Toronto Dominion Bank held 3,173,258 shares of Stoke Therapeutics worth $103M as of Q1 2026.
  • Toronto Dominion Bank left its Stoke Therapeutics share count unchanged in Q1 2026.
  • Stoke Therapeutics made up 0.15% of Toronto Dominion Bank's portfolio in Q1 2026, its #126 holding.
  • Toronto Dominion Bank first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.